Ad
CANF - Can Fite Biopharma Ltd Sponsored ADR Stock Trading
About | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
None
Quote | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
| Last: | $2.24 |
|---|---|
| Change Percent: | 2.58% |
| Open: | $2.27 |
| Close: | $2.24 |
| High: | $2.3683 |
| Low: | $2.24 |
| Volume: | 14,312 |
| Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
-
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer, and liver diseases, today announced its VP of Business Development, Dr. Sari Fishman, will participate in BioEquity Eur...
-
Exploratory, small, open-label study aims to assess potential efficacy of Namodenoson following strong preclinical results in pancreatic cancer Namodenoson, now in a pivotal Phase 3 liver cancer study, has completely cleared liver cancer in a patient who remains cancer-free 6 years af...
Message Board Posts | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
| Subject | By | Source | When |
|---|---|---|---|
| A complete and total fluff | midastouch017 | investorshub | 04/24/2023 12:02:45 PM |
| Can-Fite Announces New Management Structure as Advanced Stage | midastouch017 | investorshub | 04/24/2023 11:55:17 AM |
| Can-Fite: EMA Gives Green Light for Piclidenoson Pivotal | midastouch017 | investorshub | 04/10/2023 12:34:40 PM |
| Dr. Sari Fishman, the Companys Vice President of | midastouch017 | investorshub | 03/30/2023 12:06:50 PM |
| Revenues for the year ended December 31, 2022 | midastouch017 | investorshub | 03/30/2023 11:59:37 AM |
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
